Description

Salivary antimicrobial peptide levels (SIgA, lactoferrin) at different timepoints, indicating enhanced mucosal immune defense in the vitamin D3 group.

Figure 4

Chart

Source Paper

Vitamin D₃ Supplementation Reduces the Symptoms of Upper Respiratory Tract Infection during Winter Training in Vitamin D-Insufficient Taekwondo Athletes: A …

International journal of environmental research and public health (2018)

PMID: 30223447

DOI: 10.3390/ijerph15092003

Cite This Figure

![Figure 4: Salivary antimicrobial peptide levels (SIgA, lactoferrin) at different timepoints, indicating enhanced mucosal immune defense in the vitamin D3 group.]()

> Source: Hyun Chul Jung et al. "Vitamin D₃ Supplementation Reduces the Symptoms of Upper Respiratory Tract Infec." *International journal of environmental research and public health*, 2018. PMID: [30223447](https://pubmed.ncbi.nlm.nih.gov/30223447/)

<figure>
  <img src="" alt="Salivary antimicrobial peptide levels (SIgA, lactoferrin) at different timepoints, indicating enhanced mucosal immune defense in the vitamin D3 group." />
  <figcaption>Figure 4. Salivary antimicrobial peptide levels (SIgA, lactoferrin) at different timepoints, indicating enhanced mucosal immune defense in the vitamin D3 group.<br>  Source: Hyun Chul Jung et al. "Vitamin D₃ Supplementation Reduces the Symptoms of Upper Respiratory Tract Infec." <em>International journal of environmental research and public health</em>, 2018. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/30223447/">30223447</a></figcaption>
</figure>

Preuves associées

Vitamin D pour Upper Respiratory Tract Infections

Note A · 40 études